Literature DB >> 2458315

The human LFA-3 gene is located at the same chromosome band as the gene for its receptor CD2.

W A Sewell1, R W Palmer, N K Spurr, D Sheer, M H Brown, Y Bell, M J Crumpton.   

Abstract

Lymphocyte function-associated antigen 3 (LFA-3) is a widely distributed cell surface glycoprotein that has been assigned a role in cell-cell adhesion on the basis of its capacity to bind to the T-lymphocyte CD2 antigen. The amino acid sequences of the extracellular domains of these two antigens, predicted from their cDNA sequences, show significant similarities, and both are members of the immunoglobulin supergene family. In this communication, a probe prepared from LFA-3 cDNA has been used in Southern blot analyses of somatic cell hybrids and in in situ hybridization to assign the LFA-3 gene to the human chromosome band 1p13. This is the same location previously assigned to CD2. Thus the LFA-3 and CD2 genes have probably arisen by duplication of a common evolutionary precursor. These genes therefore represent a further instance in which related members of the immunoglobulin superfamily are located in adjacent regions of the genome.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2458315     DOI: 10.1007/BF00345506

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  27 in total

1.  A year in the life of the immunoglobulin superfamily.

Authors:  A F Williams
Journal:  Immunol Today       Date:  1987

2.  An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2.

Authors:  B Seed
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

3.  Molecular cloning and expression of T11 cDNAs reveal a receptor-like structure on human T lymphocytes.

Authors:  P H Sayre; H C Chang; R E Hussey; N R Brown; N E Richardson; G Spagnoli; L K Clayton; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

4.  An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein.

Authors:  S C Meuer; R E Hussey; M Fabbi; D Fox; O Acuto; K A Fitzgerald; J C Hodgdon; J P Protentis; S F Schlossman; E L Reinherz
Journal:  Cell       Date:  1984-04       Impact factor: 41.582

5.  Differential Giemsa staining of sister chromatids and the study of chromatid exchanges without autoradiography.

Authors:  S Wolff; P Perry
Journal:  Chromosoma       Date:  1974       Impact factor: 4.316

6.  Anchoring mechanisms for LFA-3 cell adhesion glycoprotein at membrane surface.

Authors:  M L Dustin; P Selvaraj; R J Mattaliano; T A Springer
Journal:  Nature       Date:  1987 Oct 29-Nov 4       Impact factor: 49.962

7.  New regional localisations for HAGH and PGP on human chromosome 16.

Authors:  J C Mulley; D F Callen
Journal:  Hum Genet       Date:  1986-12       Impact factor: 4.132

8.  Physical linkage of three CD3 genes on human chromosome 11.

Authors:  A Tunnacliffe; L Buluwela; T H Rabbitts
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

9.  Gene for the human T cell differentiation antigen Leu-2/T8 is closely linked to the kappa light chain locus on chromosome 2.

Authors:  V P Sukhatme; A C Vollmer; J Erikson; M Isobe; C Croce; J R Parnes
Journal:  J Exp Med       Date:  1985-02-01       Impact factor: 14.307

10.  Purified lymphocyte function-associated antigen 3 binds to CD2 and mediates T lymphocyte adhesion.

Authors:  M L Dustin; M E Sanders; S Shaw; T A Springer
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

View more
  11 in total

1.  Physical linkage of genes encoding the lymphocyte adhesion molecules CD2 and its ligand LFA-3.

Authors:  S F Kingsmore; M L Watson; W S Moseley; M F Seldin
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

2.  CD1 defines conserved linkage group border between human chromosomes 1 and mouse chromosomes 1 and 3.

Authors:  W S Moseley; M L Watson; S F Kingsmore; M F Seldin
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Gene structure, chromosomal location, and basis for alternative mRNA splicing of the human VCAM1 gene.

Authors:  M I Cybulsky; J W Fries; A J Williams; P Sultan; R Eddy; M Byers; T Shows; M A Gimbrone; T Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

4.  Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34.

Authors:  M Lafage-Pochitaloff; R Costello; D Couez; J Simonetti; P Mannoni; C Mawas; D Olive
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

5.  Isolation and characterization of cDNA clones for Humly9: the human homologue of mouse Ly9.

Authors:  M S Sandrin; M M Henning; M F Lo; E Baker; G R Sutherland; I F McKenzie
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

6.  The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control study.

Authors: 
Journal:  PLoS One       Date:  2011-04-28       Impact factor: 3.240

7.  Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.

Authors:  A R Arulanandam; A Kister; M J McGregor; D F Wyss; G Wagner; E L Reinherz
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

Review 8.  CD58 Immunobiology at a Glance.

Authors:  Yalu Zhang; Qiaofei Liu; Sen Yang; Quan Liao
Journal:  Front Immunol       Date:  2021-06-08       Impact factor: 7.561

9.  A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.

Authors:  A R Arulanandam; P Moingeon; M F Concino; M A Recny; K Kato; H Yagita; S Koyasu; E L Reinherz
Journal:  J Exp Med       Date:  1993-05-01       Impact factor: 14.307

10.  CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation.

Authors:  K Kato; M Koyanagi; H Okada; T Takanashi; Y W Wong; A F Williams; K Okumura; H Yagita
Journal:  J Exp Med       Date:  1992-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.